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Hyperhomocysteinemia, a condition of elevated blood homocysteine level, is an independent risk factor for cardiovascular diseases.
Hyperhomocysteinemia is also found in patients with liver diseases. However, the direct effect of homocysteine on liver injury is not well known.
Folic acid supplementation is a promising approach for improving endothelial function in patients with hyperhomocysteinemia. The aim of this
study was to investigate the direct effect of hyperhomocysteinemia on liver injury and whether folic acid could offer any protective effect to the
liver. Hyperhomocysteinemia was induced in rats fed a high-methionine diet for 4 weeks. There was a significant increase in the serum aspartate
aminotransferase and alanine aminotransferase activities reflecting liver injury in hyperhomocysteinemic rats. Hepatic NAD(P)H oxidase was
activated during hyperhomocysteinemia leading to increased superoxide anion production and peroxynitrite formation in the liver. As a
consequence, the level of lipid peroxides was significantly elevated in livers of hyperhomocysteinemic rats. Folic acid supplementation effectively
inhibited NAD(P)H oxidase-mediated superoxide anion production leading to reduced lipid peroxidation in the liver. Folic acid supplementation
also alleviated hyperhomocysteinemia-induced liver injury. These results suggest that hyperhomocysteinemia can cause liver injury and
supplementation of folic acid offers a hepatoprotective effect.
© 2006 Elsevier B.V. All rights reserved.Keywords: Homocysteine; Folic acid; Oxidative stress; Liver function1. Introduction
Hyperhomocysteinemia is regarded as an independent risk
factor for cardiovascular diseases [1–3]. It is defined as
plasma or serum homocysteine (Hcy) levels higher than
15 μM [3]. Hcy is an intermediate amino acid formed during
the metabolism of methionine. Abnormal elevations of plasma
Hcy levels up to 100–250 μM have been reported in patients
with severe hyperhomocysteinemia due to genetic defects of
enzymes that are involved in Hcy metabolic pathways [3].
Recent evidence suggests that hyperhomocysteinemia is also
associated with diseases that involve other organs [4,5]. In an⁎ Corresponding author. Laboratory of Integrative Biology, St. Boniface
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doi:10.1016/j.bbadis.2006.05.012early study, McCully observed extensive arteriosclerosis in a
pediatric patient with severe hyperhomocysteinemia and
proposed a pathogenic link between elevated blood Hcy
levels and atherogenesis [6]. The necropsy also revealed
moderately fatty liver [6]. Subsequent investigations demon-
strated an association between hyperhomocysteinemia and
liver disease [4,7]. Plasma Hcy levels are often elevated in
patients with liver cirrhosis or chronic alcohol-induced liver
injury due to impaired Hcy metabolism [4,7]. Our recent study
demonstrated an early sign of hepatic steatosis (fatty liver) in
hyperhomocysteinemic rats [8]. Hyperhomocysteinemia
caused an activation of several transcription factors in the
liver leading to increased HMG-CoA reductase and cholesterol
biosynthesis [8]. As a consequence, hepatic lipid accumulation
and hypercholesterolemia occurred [8].
Oxidative stress due to excessive generation of reactive
oxygen species (ROS) has been suggested as one of the
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[9,10]. In our previous study, we observed that hyperhomocys-
teinemia could induce excessive superoxide anion generation
and expression of inflammatory markers as well as impairment
of endothelium-dependent vessel relaxation [9,11]. Superoxide
anion is a reactive oxygen free radical that can rapidly interact
with nitric oxide (NO) to form highly reactive peroxynitrite, a
potent oxidant that can cause tissue damage [12–14].
Nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase is the primary enzyme for superoxide anion generation
[15]. The activation of NAD(P)H oxidase leads to a massive
production of reactive oxygen species (ROS) including super-
oxide anion as an initial product. Increased superoxide anion
production is thought to be one of the important mechanisms
contributing to liver injury [16,17]. Inhibition of NAD(P)H
oxidase expression protected the liver against alcohol-induced
injury in rodent models [16,17].
Hcy can be metabolized via two major pathways, namely,
remethylation pathway and transsulfuration pathway. In the
remethylation pathway, Hcy can be converted to methionine
catalyzed by methionine synthase with folate as a co-substrate
or catalyzed by betaine-Hcy methyltransferase using betaine as
a co-substrate. In the transsulfuration pathway, Hcy is
irreversibly converted to cystathionine by cystathionine β-
synthase (CBS). Factors that perturb the steps in Hcy metabolic
pathways can cause an increase in cellular Hcy levels and lead
to its elevation in the blood [3,18]. Folic acid is a synthetic form
of folate that is a water soluble B vitamin. The active metabolite
of folic acid is 5-methyltetrahydrofolate that facilitates the
remethylation of Hcy to methionine. Oral folic acid supple-
mentation has been shown to reduce plasma Hcy levels as well
as improve the endothelial function in individuals with mild
hyperhomocysteinemia [19]. We previously observed that
hyperhomocysteinemia could be induced in rats fed a high
methionine diet for 4 weeks [8,9,11]. In this animal model, folic
acid supplementation abolished Hcy-induced expression of
chemokines and adhesion molecules in the aortic endothelium
[11].
At present, the direct effect of hyperhomocysteinemia on
liver injury is not well known. Although folic acid supplemen-
tation is viewed as a promising approach for the prevention and
treatment of cardiovascular disease associated with hyperho-
mocysteinemia or with other risk factors [19–21], its role in
liver injury remains to be examined. In this study, we
investigated the effect of hyperhomocysteinemia and folic
acid supplementation on hepatic oxidative stress and liver injury
in hyperhomocysteinemic rats.
2. Materials and methods
2.1. Animal model
Male Sprague–Dawley rats (Charles River Laboratories, Wilmington, MA,
USA) aged 8 weeks were divided into five groups and maintained for 4 weeks
on the following diets: (1) control diet (regular diet) consisting of Lab Diet
Rodent Diet 5001 (PMI Nutrition International, St. Louis, MO, USA) which
contained 0.43% (wt/wt, 4.3 g/kg) methionine, 0.00059% (wt/wt, 5.9 mg/kg)
folic acid and 0.0006% (wt/wt, 6 mg/kg) vitamin B6; (2) high-methionine dietconsisting of regular diet plus 1.7% (wt/wt) methionine; and (3) high-
methionine plus folic acid diet, consisting of regular diet plus 1.7% (wt/wt)
methionine and 0.025% (wt/wt, 250 mg/kg) folic acid; (4) high-methionine plus
folic acid and vitamin B6 diet, consisting of regular diet plus 1.7% (wt/wt)
methionine, 0.025% (wt/wt) folic acid and 0.006% (wt/wt, 60 mg/kg) vitamin
B6; (5) high-methionine plus vitamin B6 diet, consisting of regular diet plus
1.7% (wt/wt) methionine and 0.006% (wt/wt) vitamin B6 [8,9,11,22]. Results
from our previous studies demonstrated that hyperhomocysteinemia could be
induced in rats after 4 weeks of high-methionine diet [8,9,11]. The Hcy and
folate concentrations in the serum were measured with the IMx assays (Abbott
Diagnostics, Abbott Park, IL, USA) and DELFIA® Folate kit (PerkinElmer,
Boston, MA, USA), respectively [8,9,11]. The liver injury was assessed by
measuring the activity of aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) in serum samples with enzymatic kits (Wako
Chemicals, Richmond, VA, USA). All procedures were performed in
accordance with the Guide to the Care and Use of Experimental Animals
published by Canadian Council on Animal Care and approved by University of
Manitoba Protocol Management and Review Committee.
2.2. Immunohistochemical staining
Immunohistochemical staining for nitrotyrosine protein adducts was
performed. In brief, the liver was excised and a portion of it was immersion-
fixed in 10% neutral-buffered formalin overnight followed by embedding in
paraffin. Sequential 5 μm paraffin-embedded cross sections were prepared
[8,23]. Sections were stained with nitrotyrosine protein adducts [23]. In brief,
sections were incubated with 2% BSA blocking agent following permeabiliza-
tion. Mouse anti- nitrotyrosine antibodies (1:100) (Zymed Laboratories, South
San Francisco, CA, USA) were used as primary antibody. Sections were treated
with 0.3% hydrogen peroxide (H2O2) for 20 min at room temperature to inhibit
the endogenous peroxidase. The sections were then incubated with biotin-
conjugated anti-mouse immunoglobulins (1:200, DakoCytomation, Carpinteria,
CA, USA) as secondary antibodies followed by peroxidase conjugated-
streptavidin (Zymed). Sections were then treated with 3,3-diaminobenzidine
(DAB)-H2O2 colorimetric substrate solution. The attached peroxidase catalyzed
the H2O2-mediated oxidation of DAB to yield an insoluble brown precipitate.
The area displayed brownish color indicating the nitrotyrosine protein adducts
[23]. The images (5 per liver) were captured and examined using an Axioskop2
MOT microscope (Carl Zeiss Microimaging, Thornwood, NY, USA), an
Axiocam camera, and Photoshop 6.0 (Adobe, San Jose, CA, USA).
2.3. Determination of NAD(P)H oxidase activity and
antioxidant enzyme activities
The NAD(P)H oxidase activity was measured by lucigenin chemilumines-
cence's assay [24]. A portion of the liver was homogenized in a 50 mM
phosphate buffer (pH 7.0, 1:10, w/v) containing 1 mM ethylenediaminete-
traacetic acid (EDTA) and 1 mM phenylmethylsulfonyl fluoride (PMSF). After
centrifugation at 3000×g for 10 min, an aliquot of the supernatant (100 μg
proteins) were incubated with lucigenin (5 μM) in a phosphate buffer (50 mM,
pH 7.0) for 2 min followed by adding the substrate, 100 μM NADPH [24].
Chemiluminescent signal (photon emission) was measured every 15 s for 3 min
using a luminometer (Lumet LB9507, Berthold Technologies GmbH and Co.
KG, BadWildbad, Germany). In principle, reaction of lucigenin with superoxide
anion leads to the formation of lucigenin dioxetane that decomposes to produce
two molecules of N-methylacridone [25]. One of these two N-methylacridone
molecules is in an electronically excited state and emits a photon. The photon
emission that reflects the amount of superoxide anion in the sample can be
detected using a luminometer [25]. A standard curve was prepared with xanthine
(100 μM) and known serial concentrations of xanthine oxidase (Sigma-Aldrich,
St. Louis, MO, USA). The NAD(P)H oxidase activity was calculated based on
the amount of superoxide anion produced in the reaction mixture. To verify that
the photon signal detected in livers of hyperhomocysteinemic rats was mainly
generated from NAD(P)H oxidase, the same experiments were performed using
sodium succinate, arginine or xanthine as a substrate in the lucigenin
chemiluminescence assay. In assays using those substrates, a negligible
chemiluminescent signal was detected. In addition, hepatic superoxide
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determined as previously described [26,27].
2.4. Determination of superoxide anion
The level of superoxide anion in the liver was determined as previously
described with minor modification [9]. A portion of the liver was homogenized
in a buffer (1:4, w/v) containing 20 mM HEPES, 1 mM EDTA and 0.1 mM
PMSF. After centrifugation at 3000×g for 10 min, an aliquot of supernatant was
incubated in a reaction mixture containing 10 μM dihydroethidium for 30 min at
37 °C. The superoxide anion in the liver homogenate caused the oxidation of
dihydroethidium leading to the formation of ethidium which was detected at an
excitation of 475 nm and an emission of 610 nm using a fluorometer (Spectra
Max Gemini, Molecular Devices, Sunnyvale, CA, USA). The fluorescent signal
produced by ethidium was proportional to the level of superoxide anion present
in the liver.
2.5. Determination of nitric oxide synthase (NOS) activity and
NO metabolites
Total NOS activity in the liver was measured using L-citrulline assay [28]. In
brief, a portion of the liver was homogenized in a lysis buffer (1:4 w/v) containing
50 mM Tris, 0.1 mM ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic
acid (EGTA), 0.1mMEDTA, 2μMleupeptin, 1mMPMSF, 1% (v/v) Nonidet P-40,
0.1% sodium dodecyl sulfate (SDS), 0.1% deoxycholate, pH 7.5 followed by
centrifugation at 3000×g for 10 min [28]. An aliquot of the supernatant was
incubated in a reaction mixture containing 50 mM Tris, 1 mM NADPH, 3 μM
tetrahydrobiopterin, 100mMcalmodulin, 2.5mMCaCl2, 50mML-valine, 10μML-
arginine and 0.2 μCi L-[3H]-arginine as a substrate at 37 °C for 1 h. The reaction was
stopped by adding a cold stopping buffer including 20 mM HEPES, 2 mM EDTA
and 2 mM EGTA, pH 5.5. The radiolabeled reaction product, L-citrulline was
purified by anion exchange chromatographywithDowexAG50WX-8 resin column
(Bio-Rad, Hercules, CA, USA). The radioactivity associated with L-citrulline was
measured with a scintillation counter and the NOS activity was calculated [28]. The
measurement of nitrite and nitrate was used to assess the NO levels in liver tissue
[29]. In brief, a portion of the liver was homogenized in a buffer containing 20 mM
Tris, 2 mM EDTA, pH 7.4. After deproteinization, the amount of nitrite and nitrate
was determinedwithGriess reactionmethod based on the azo coupling reaction [29].
In brief, the supernatant was incubated with nitrate reductase to reduce nitrate to
nitrite. The 12.5 mM sulfanilamide in 6 M HCl and 12.5 mM N-(1-naphthyl)
ethylenediamine were then added to the reaction to complete the azo coupling
reaction. The diazoamino benzene formed in the reaction mixture was measured by
spectrophotometer at absorbance of 520 nm. The NaNO2 at different concentrations
was used as standards.
2.6. Determination of lipid peroxidation
The degree of lipid peroxidation in the liver tissue was determined by
measuring thiobarbituric acid reactive substances (TBARS) [30,31]. Briefly,
a portion of the liver was homogenized in 1.14% KCl solution containing
50 mM desferroxamine in 1:10 volumes followed by centrifugation at
3000×g for 10 min at 4 °C. An aliquot of supernatant (0.1 mL) was added
to the reaction mixture containing 0.1 mL 8% SDS, 0.375 mL 20% aceticTable 1
Serum concentrations of Hcy and folate, and aminotransferase activities
Diet Hcy (μM) F
Control 3.52±0.34
High-methionine 25.48±3.01*
High-methionine plus Folic acid 18.66±1.39*# 2
High-methionine plus Apocynin 26.28±5.84*
Rats were fed with following diets for 4 weeks: a regular diet (Control), a high methio
One group of high-methionine fed rats was given IP injection of apocynin (4 mg/kg, d
*P<0.05 compared with control values. #P<0.05 compared with values of high-m
activities of serum aspartate aminotransferase (AST) and alanine aminotransferase (acid, 0.375 mL 0.8% thiobarbituric acid and 0.1 mL water. After incubation
at 95 °C for 1 h, the amount of malondialdehyde (MDA) formed in the
reaction mixture was measured by spectrophotometer at absorbance of
532 nm. The MDA was used as the standard and the results were expressed
as nmol MDA produced per mg protein. The amount of MDA correlated to
the level of lipid peroxides in the liver.
2.7. Statistical analysis
Results were analyzed by a two-tailed Student's t-test or using one-way
analysis of variance (ANOVA) followed by Pearson's correlation test. Data were
presented as the means±S.E.M. P values less than 0.05 were considered
significant.3. Results
3.1. Induction of hyperhomocysteinemia and detection of liver
injury
Hyperhomocysteinemia was induced in rats fed a high-
methionine diet for 4 weeks. A significant increase in serumHcy
concentrations was detected in this group of rats (25.48 μM
versus 3.52 μM in control) (Table 1). Supplementation of folic
acid to rats fed a high-methionine diet lowered the serum Hcy
levels from 25.48 μM to 18.66 μM (Table 1). The serum folic
acid concentration in high-methionine plus folic acid fed group
was 2.9-fold higher than that in the control or in high-methionine
fed group (Table 1). To determine whether hyperhomocysteine-
mia resulted in liver injury, the serum aminotransferase activities
were measured. The serum aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) activities in hyperhomo-
cysteinemic rats were significantly elevated, indicating liver
injury (Table 1). Supplementation of folic acid to rats fed a high-
methionine diet effectively alleviated liver injury as demon-
strated by a reduction of both AST and ALT activities (Table 1).
These results suggested that 4-week exposure to hyperhomo-
cysteinemia was able to cause liver injury and folic acid
supplementation had a protective effect against Hcy-induced
liver injury.
3.2. Increased NAD(P)H oxidase dependent superoxide
production in the liver
The NAD(P)H oxidase activity was significantly increased in
livers of hyperhomocysteinemic rats (Fig. 1A). In accordance,
there was a significant elevation of superoxide anion levels inolate (ng/mL) AST (IU/L) ALT (IU/L)
89.43±7.13 26.62±3.82 36.28±6.06
89.70±7.58 42.89±7.60* 60.62±9.54*
55.94±24.94*# 34.07±4.47 45.39±4.10
86.21±15.49 28.56±2.08 42.82±8.75
nine diet (1.7%) or a high methionine plus folic acid diet (n=12 for each group).
aily) for 3 days prior to euthanasia (n=8). Values were expressed mean±S.E.M.
ethionine treated group. Liver injury was examined by measuring the enzyme
ALT).
Fig. 1. NAD(P)H oxidase activity and superoxide anion content in rat livers. Rats
were fedwith following diets for 4weeks: a regular diet (Control), a highmethionine
diet (1.7%, Met), or a high methionine plus folic acid diet (Met+Folic acid) (n=12
for each group). One group of high-methionine fed rats was given IP injection of
apocynin (4 mg/kg, daily) for 3 days prior to euthanasia (Met+Apocynin) (n=8).
Livers were isolated and (A) NAD(P)H oxidase activity (expressed as the amount of
superoxide anion produced per mg of protein per min) and (B) the superoxide anion
level in the liver tissue was determined. Results were expressed as mean±S.E.M.
*P<0.05 compared with control values. #P<0.05 compared with values of high-
methionine treated group.
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supplementation reduced the NAD(P)H oxidase activity and the
superoxide anion content to the basal levels (Fig. 1). Treatment
of hyperhomocysteinemic rats with apocynin, an inhibitor for
NADPH oxidase [16], completely blocked hyperhomocysteine-
mia-induced NAD(P)H oxidase activation and elevation of
superoxide anion levels in the liver (Fig. 1). Folic acid
supplementation also reversed liver injury as demonstrated by
a reduction of both AST and ALT activities (Table 1). Similar
results were observed in hyperhomocysteinemic rats treated with
apocynin (Table 1). To test whether increased superoxide anion
production was derived from the mitochondrial respiration
system, experiments were performed by adding rotenone (an
inhibitor of mitochondrial respiration) to the lucigenin chemi-
luminescence assay mixture [25]. Such treatment did not affect
hyperhomocysteinemia-induced superoxide anion generation in
the liver tissue (data not shown). These results suggested that
hyperhomocysteinemia-induced liver injury might be mediated
via oxidative stress due to increased NAD(P)H oxidase
dependent superoxide anion production. Folic acid supplemen-
tation exerted a protective effect against liver injury.3.3. Increased nitrotyrosine formation in the liver during
hyperhomocysteinemia
Superoxide anion can react with nitric oxide (NO) to form
peroxynitrite. To determine whether there was an increase in
peroxynitrite formation in the liver during hyperhomocysteine-
mia, immunohistochemical analysis was performed to detect
nitrotyrosine, a biomarker for peroxynitrite [32]. Little nitrotyr-
osine protein adducts were detected in the liver samples isolated
from control rats (Fig. 2A). In contrast to the control, a
significant increase in the intensity of nitrotyrosine protein adduct
staining was found in the livers of hyperhomocysteinemic rats
(Fig. 2B), indicating an increased peroxynitrite formation. Rats
treated with folic acid supplementation displayed much less
staining of nitrotyrosine protein adducts in the liver samples (Fig.
2C). Treatment of hyperhomocysteinemic rats with apocynin
completely blocked hyperhomocysteinemia-induced nitrotyrosine
formation in the liver (Fig. 2D). Next, to determine whether
hyperhomocysteinemia also stimulated NO production in the
liver, the level of NO metabolites (nitrite and nitrate) and the
NOS activity were measured. There was no change in the NO
metabolite levels (Fig. 3A) or the NOS activity (Fig. 3B) in the
livers of hyperhomocysteinemic rats. These results indicated that
increased peroxynitrite formation in the liver during hyperhomo-
cysteinemia was mainly due to excessive superoxide anion
generation. Folic acid supplementation could antagonize Hcy-
induced peroxynitrite formation (Fig. 2C).
3.4. Increased hepatic lipid peroxidation during
hyperhomocysteinemia
Peroxynitrite is a potent oxidant and can cause lipid
peroxidation, which is detrimental to tissues [33]. The degree
of lipid peroxidation in the liver was examined by measuring the
level of malondialdehyde (MDA), an indicator of lipid
peroxidation. The MDA level was significantly elevated in the
livers of hyperhomocysteinemic rats, reflecting an increased
lipid peroxidation in the liver (Fig. 4). Folic acid supplementa-
tion reduced the liver MDA level to the value similar to that
observed in the control rats (Fig. 4). Apocynin treatment also
reduced the MDA level in hyperhomocysteinemic rats to the
basal level (Fig. 4). These results suggested that NAD(P)H
oxidase-mediated superoxide anion generation was responsible
for oxidative stress and subsequently increased lipid peroxida-
tion during hyperhomocysteinemia.
3.5. Decrease in hepatic antioxidant enzyme activities during
hyperhomocysteinemia
Oxidative stress might also be a result of a decrease in
antioxidant enzyme activities. Therefore, several antioxidant
enzymes including superoxide dismutase (SOD), catalase and
glutathione peroxidase (GPx) were examined. As shown in Fig.
5, the activity of hepatic SOD and catalase was significantly
decreased in hyperhomocysteinemic rats while the glutathione
peroxidase (GPx) activity remained unchanged during
hyperhomocysteinemia.
Fig. 2. Immunohistochemical staining of nitrotyrosine in rat livers. Livers were fixed in 10% neutral-buffered formalin overnight and then embedded in paraffin.
Immunohistochemical staining for nitrotyrosine protein adducts was performed with anti-nitrotyrosine antibodies. After counterstaining with Mayer's hematoxylin,
nitrotyrosine was identified under light microscope with a magnification of 200×. Representative photos were obtained from rats fed (A) a regular diet (Control), (B)
high-methionine diet (1.7%, Met), (C) high-methionine plus folic acid diet (Met+Folic acid) (n=12 for each group), and (D) high-methionine plus IP injection of
apocynin (4 mg/kg, daily) for 3 days prior to euthanasia (Met+Apocynin) (n=8). (E) The positive control was prepared from rats with IP injection of 300 mg/kg
acetaminophen 6 h prior to euthanasia. Arrows point to the areas positively stained with nitrotyrosine. The intensity of stained area for nitrotyrosine was quantified
using Photoshop 6.0 (bottom panel). The results were expressed as mean±S.E.M. *P<0.05 compared with control values. #P<0.05 compared with values of high-
methionine treated group (Scale bar=20 μm).
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combination with folic acid
The effect of vitamin B6 supplementation was examined.
Vitamin B6 supplementation to rats fed a high-methioninediet lowered the serum Hcy level from 25.48 μM to
17.17 μM (Fig. 6A). Combination of folic acid with vitamin
B6 did not produce further reduction in the serum Hcy level.
Inhibition of hepatic NAD(P)H oxidase activity and MDA
production were observed in rats supplemented with folic
Fig. 3. Hepatic NOS activity and NO production. Rats were fed with following
diets for 4 weeks: a regular diet (Control), a high methionine diet (1.7%, Met),
or a high methionine plus folic acid diet (Met+Folic acid). (A) The total
hepatic NOS activity in the liver was determined and expressed as the amount
of L-citrulline produced per mg of protein per minute. (B) The levels of NO
metabolites (nitrite and nitrate) were measured and expressed as the amount of
nitrite and nitrate per g of wet weight of liver tissue. Results were expressed as
mean±S.E.M. (n=12).
Fig. 4. Determination of lipid peroxidation in rat livers. Rats were fed with
following diets for 4weeks: a regular diet (Control), a highmethionine diet (1.7%,
Met), a high methionine plus folic acid diet (Met+Folic acid) (n=12 for each
group) or high-methionine plus 3 days treatment of apocynin (Met+Apocynin)
(n=8). Lipid peroxides (TBARS) in the livers was determined by measuring the
amount of MDA in the liver tissue. The level of MDAwas expressed as nmol per
g of protein. Results were expressed as mean±S.E.M. *P<0.05 compared with
control values. #P<0.05 compared with values of high-methionine treated group.
Fig. 5. Hepatic antioxidant enzymes activities. Rats were fed with following
diets for 4 weeks: a regular diet (Control), a high methionine diet (1.7%, Met), a
high methionine plus folic acid diet (Met+Folic acid) (n=12 for each group) or
high-methionine plus 3 days treatment of apocynin (Met+Apocynin) (n=8). (A)
Superoxide dismutase (SOD), (B) catalase and (C) glutathione peroxidase (GPx)
activities were determined in the liver tissue and expressed as percentage of
control. Results were expressed as mean±S.E.M. *P<0.05 compared with
control values.
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(Fig. 6B, C). Liver injury was further examined by
measuring serum AST and ALT enzyme activities. Supple-
mentation of folic acid or folic acid combined with vitamin
B6 was able to reduce AST and ALT activities (data not
shown).
3.7. Correlation between serum Hcy concentrations and
oxidative stress
To examine the correlation between serum Hcy concen-
trations and oxidative stress, hyperhomocysteinemia was
induced in rats fed 0.8% methionine or 1.7% methionine.
There was a significant elevation of serum Hcy level in rats
fed 0.8% methionine (7.47 μM vs. 3.52 μM in the control
group) (Fig. 7A). In rats fed 1.7% methionine, the serum
Fig. 6. The protective effects of folic acid and vitamin B6. Rats were fed with
following diets for 4 weeks: a regular diet (Control), a high methionine diet
(1.7%, Met), a high methionine plus folic acid diet (Met+Folic acid), a high-
methionine plus folic acid and vitamin B6 (Met+Folic acid+Vitamin B6) or a
high-methionine plus vitamin B6 (Met+Vitamin B6). (A) Serum Hcy levels
were determined. (B) The NAD(P)H oxidase activity were measured and
expressed as the amount of superoxide anion produced per mg of protein per
min. (C) Lipid peroxides (TBARS) in the livers were determined by measuring
the amount of MDA in the liver tissue. Results were expressed as mean±S.E.M.
*P<0.05 compared with control values. #P<0.05 compared with values of high-
methionine treated group.
Fig. 7. Determination of hepatic lipid peroxidation. Rats were fed with following
diets for 4 weeks: a regular diet (Control), a 0.8% methionine diet (0.8% Met),
and a 1.7% methionine diet (1.7% Met) (n=4 for each group). (A) Serum Hcy
levels were determined. (B) Lipid peroxides (TBARS) in the livers were
determined by measuring the amount of MDA in the liver tissue. Results were
expressed as mean±S.E.M. *P<0.05 compared with control values.
662 C.W.H. Woo et al. / Biochimica et Biophysica Acta 1762 (2006) 656–665Hcy level was elevated to 25.48 μM. The degree of lipid
peroxidation in livers of those rats was examined. As shown
in Fig. 7B, there was a significant increase in lipid
peroxidation in livers of rats fed 1.7% methionine. However,
the degree of lipid peroxidation in livers of 0.8%
methionine-fed rats was similar to that found in the control
group (Fig. 7B). Further analysis revealed that there was a
significant correlation between the serum Hcy concentration
and the hepatic superoxide anion level in rats fed high-
methionine diet (Fig. 8A). The correlation coefficient was
further increased when data with serum Hcy concentrations
higher than 19 μM were analyzed (Fig. 8B). However, whendata with serum Hcy concentration less than 19 μM were
subjected to the same analysis, the correlation coefficient
value was 0.22 and no significance was observed (Fig. 8C).
4. Discussion
The novel findings of this study are that (1) in the absence of
other risk factors, diet-induced hyperhomocysteinemia alone
can cause liver injury due to oxidative stress; (2) folic acid
supplementation can reduce superoxide anion generation and
alleviate hyperhomocysteinemia-induced liver injury.
Oxidative stress due to NAD(P)H oxidase-mediated super-
oxide anion generation is thought to be one of the important
mechanisms for Hcy-induced cardiovascular dysfunction [9].
NAD(P)H oxidase is abundantly expressed in phagocytic cells
and plays a major role in immune defense against micro-
organism invasion. The NAD(P)H oxidase is also expressed in
non-phagocytic cells. The ROS generated by non-phagocytic
NAD(P)H oxidase are involved in cell signaling, proliferation,
apoptosis and cellular senescence [34]. The phagocytic NAD
(P)H oxidase consists of cytosolic subunits (p47phox, p67phox,
p40phox and rac) and membrane-bound subunits (p22phox and
gp91phox) [35,36]. In non-phagocytic cells, homologues of
gp91phox subunit have been identified including Nox and
Duox [35]. Nox and Duox mRNA have been found in rat
hepatocytes [37]. Several studies suggest that Kupffer cell
(liver residing macrophage)-derived ROS exacerbates liver
Fig. 8. Correlation of serum Hcy levels and hepatic superoxide anion content.
Pearson's correlation between serum Hcy levels and hepatic superoxide anion
content in (A) samples with the whole range of serumHcy levels; (B) serum Hcy
levels above 19 μMand (C) serumHcy levels below 19 μMwere analyzed. Both
r and P values were calculated.
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acids can activate NAD(P)H oxidase in hepatocytes leading to
oxidative stress mediated apoptosis [40]. Several lines of
evidence from the present study suggested that hyperhomo-
cysteinemia-induced liver injury was mediated via oxidative
stress. First, there was a significant increase in peroxynitrite
formation in the liver of hyperhomocysteinemic rat. An
increase in the level of peroxynitrite in the liver could be
due to an elevation of superoxide anion and/or NO levels. Our
results clearly demonstrated that activation of NAD(P)H
oxidase during hyperhomocysteinemia caused an increase in
superoxide anion production in the liver. A significantcorrelation coefficient value between the serum Hcy level
and hepatic superoxide anion content was observed. On the
other hand, NOS activity and NO concentration were not
altered in the liver during hyperhomocysteinemia. These
results suggested that peroxynitrite formation in the liver
was mainly due to Hcy-induced superoxide anion production.
Second, peroxynitrite is a potent oxidant that can damage cells
by modifying lipids, proteins and DNA. There was a
significant increase in the levels of lipid peroxides and
nitrotyrosine protein adducts in the livers of hyperhomocys-
teinemic rats, suggesting oxidative damage occurred. Third,
the involvement of NAD(P)H oxidase was furthered confirmed
by using a known NAD(P)H oxidase inhibitor, apocynin. The
NAD(P)H oxidase activity, superoxide anion level, peroxyni-
trite formation as well as lipid peroxidation were reduced to
the basal levels in hyperhomocysteinemic rats that were treated
with apocynin. Taken together, these results indicate that NAD
(P)H oxidase dependent superoxide anion generation plays a
major role in Hcy-induced oxidative stress in liver injury
during hyperhomocysteinemia.
Folic acid supplementation is viewed as a promising
treatment for patients with cardiovascular disease associated
with hyperhomocysteinemia. Oral folic acid supplementation
has been shown to improve the endothelium-dependent
vascular function in patients with mild hyperhomocysteinemia
[19–21]. The mechanisms underlying such an effect are not
fully understood. It has been proposed that the beneficial effect
of folic acid in cardiovascular disease is attributed to Hcy
reduction as well as its ability to antagonize oxidative stress
[19–21]. In the present study, folic acid supplementation to rats
fed a high-methionine diet resulted in a 2.9-fold increase in the
serum folate level as compared to the control group. Such a
treatment led to a significant reduction in the serum Hcy level
(from 25.48 μM to 18.66 μM). Although the serum Hcy level
in rats fed a high-methionine diet plus folic acid was still
significantly higher than that found in the control group
(18.66 μM versus 3.52 μM), folic acid supplementation
completely abolished hyperhomocysteinemia-induced super-
oxide anion generation, peroxynitrite formation, lipid perox-
idation in the liver. Furthermore, folic acid supplementation
could alleviate liver injury in hyperhomocysteinemic rats. It is
tempting to speculate that the hepatic protective effect of folic
acid supplementation may be mediated, in part, via its direct
action that is independent of its Hcy lowering effect. On the
other hand, it is possible that reduction of serum Hcy levels by
folic acid supplementation below a certain threshold may be
able to abolish hyperhomocysteinemia-induced oxidative stress
and liver injury. Although Hcy at the serum concentration of
18.66 μM did not elicit oxidative stress and liver injury, it
remains to be investigated whether such a reduction of serum
Hcy levels in rats by folic acid supplementation is sufficient to
improve endothelial function. Interestingly, in rats fed 0.8%
methionine diet, the serum Hcy level was double of the control
value but there was no increase in hepatic lipid peroxidation
(Fig. 7). Furthermore, vitamin B6 supplementation caused Hcy-
lowering effect similar to that of folic acid supplementation and
effectively abolished Hcy-induced oxidative stress (Fig. 6).
664 C.W.H. Woo et al. / Biochimica et Biophysica Acta 1762 (2006) 656–665These results suggested that decreasing Hcy to a certain level
might be sufficient to prevent hepatic oxidative stress.
However, results from the present study could not rule out
the possibility of direct effect of folic acid or vitamin B6
against oxidative stress.
To the best of our knowledge, this is the first study to show
that in the absence of other known risk factors, diet-induced
hyperhomocysteinemia can cause liver injury and folic acid
supplementation offers a hepatoprotective effect. Increased
superoxide anion generation may serve as one of the
mechanisms for Hcy-induced oxidative stress and liver injury.
Our results suggest that the role of folic acid in maintaining
good health may extend beyond the cardiovascular system to
encompass the hyperhomocysteinemia-associated disorders that
involve other organs such as liver.
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